The green light for drugmaker Regeneron came after REGEN-COV2, a combination of two lab-made antibodies, was shown to reduce Covid-19-related hospitalizations or emergency room visits in patients with underlying conditions.from US News Headlines, Latest USA News, US Election 2020 news on Times of India https://ift.tt/2HrscM4
0 Comments